ScotRail All-Aboard for MND Scotland
The ScotRail Alliance has announced it will be continuing its journey to a cure for Motor Neurone Disease (MND), by supporting charity MND Scotland for another two years.
The partnership, which was set to end in March 2020, has been a huge success, with staff and customers raising £255,000 since 2017, smashing their target of £150,000.
Going above and beyond for the past three years, funds have been raised through staff fundraising, customer donations and gifts in kind, such as advertising on trains and in stations.
MND is a rapidly progressing terminal illness, which stops signals from the brain reaching the muscles. This may cause someone to lose the ability to walk, talk, eat, drink or breathe unaided.
MND Scotland provides vital support to families affected by MND when they need it the most, and fund ground-breaking research into a cure.
Last month the charity announced a £1.5million investment into the UK’s biggest MND drug trial. Funds raised through the ScotRail Alliance – a partnership between ScotRail and Network Rail Scotland have contributed to this monumental step towards finding a cure for the disease and giving people living with MND hope.
Alex Hynes, Managing Director of Scotland’s Railway, said: “I am absolutely delighted that we will be continuing our work with MND Scotland over the next two years.
“MND Scotland is an incredible charity doing extraordinary work right across our country, and the recent drug trials show just how valuable our fundraising efforts can be.
“I’m really proud of our people and customers who have helped to raise more than £250,000 for this great cause so far, and I’m looking forward to raising even more over the next two years.”
Iain McWhirter, MND Scotland’s Head of Fundraising, said: “We are delighted that the ScotRail Alliance are going to be joining us on our journey to a cure for another two years.
“We have been blown away by the support we have received, from staff jumping out planes and organising coffee mornings, to customers donating across the country, and advertising which has helped raise awareness with commuters throughout Scotland.
“Thanks to the generosity of supporters like this we have been able to fund the most comprehensive MND drug trial in a generation. This trial will be open to almost every person with MND in Scotland and we hope will lead to finding effective treatments and ultimately a cure for MND.”